Respiratory Care Devices Market Size in 2023 To 2029 | Koninklijke Philips N.V. (Netherlands), General Electric Healthcare (US), ResMed Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Masimo Corporation (U

The Respiratory Care Devices research report provides an in-depth analysis of the market for respiratory care devices, offering comprehensive coverage of key aspects. It segments the market based on various criteria, including type, end-user/application, product offerings, and geographical regions.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 + 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐓𝐎𝐂 ➡️ https://www.reportsnreports.com/contacts/requestsample.aspx?name=423097

𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐩𝐫𝐨𝐟𝐢𝐥𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭
The prominent players in the respiratory care devices market include Koninklijke Philips N.V. (Netherlands), General Electric Healthcare (US), ResMed Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Masimo Corporation (US), Drägerwerk AG & Co.(Germany), Getinge AB (Sweden), Nihon Kohden Corporation (US), Vyaire Medical (US), Hill-Rom, Inc. (US), AdaptHealth LLC (US), Rotech Healthcare, Inc. (US), Teleflex Incorporated(Japan), Air Liquide (France), Invacare Corporation (US), ICU Medical Inc. (US), Hamilton Medical AG (Switzerland), Apex Medical Corporation (Taiwan), Apex Medical Corporation (US), HUM GmbH (Germany), Nonin Medical (US), Allied Healthcare Products, Inc. (US), Drive DeVilbiss Healthcare (US), OMRON Healthcare, Inc. (Japan).

This report extends its global reach, with a primary focus on regions like Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Furthermore, it delves into the specifics of country-wise markets, encompassing emerging economies such as India, China, the United States, the United Kingdom, France, Germany, Japan, and more.

The Respiratory Care Devices research report also highlights the latest technological advancements within the industry, empowering buyers to stay abreast of the market's most recent developments. Stakeholders can gain insights into the market's dynamics, including valuable approximations of revenue shares, market size, and current trends.

Additionally, the report offers valuable data on market drivers, restraints, challenges, and opportunities, providing a comprehensive understanding of the industry's behavior. It outlines a forward-looking trajectory that can guide companies and other stakeholders in making informed decisions for sustained profitability in the years to come. This report presents a practical overview of the global respiratory care devices market and its evolving landscape, aiding readers in making informed choices regarding their market ventures. The primary focus of this report is on growth opportunities that enable the market to expand its operations within existing markets.

The global respiratory care devices market is projected to reach USD 31.8 billion by 2028 from USD 21.8 billion in 2023, at a CAGR of 7.8%. Rising prevalence of respiratory diseases as a result of the rapid growth in the global geriatric population will drive the market growth.

COPD and asthma are the most prevalent respiratory disorders across the globe. As per the WHO, COPD is the third leading cause of death worldwide, causing 3.2 million deaths in 2019. More than 80% of these deaths have occurred in low and middle-income countries. Over 380 million people globally are anticipated to have COPD. Largely undiagnosed COPD patients are high in regions and countries, such as China, India, Brazil, and Eastern Europe. The cost incurred to healthcare systems for COPD across the globe is nearly USD 50 billion annually. Some of the major causes of COPD are long-term asthma and prolonged exposure to tobacco smoke, indoor & outdoor air pollution, and occupational fumes & dust. Other comorbid chronic conditions, including cardiovascular disease, musculoskeletal impairment, and diabetes mellitus, are related to COPD. These conditions may also impact the health status of patients, as well as interfere with COPD management.

"The ventilators segment holds the major share of the therapeutic respiratory care devices market"

The therapeutic respiratory care devices market is segmented into ventilators, positive airway pressure (PAP) devices, humidifiers, nebulizers, oxygen concentrators, reusable resuscitators, inhalers, masks, nitric oxide delivery units, and oxygen hoods. In 2022, the ventilators segment holds the major share of the therapeutic respiratory care devices market. A large share of the ventilator segment can be attributed to the rising number of intensive care beds equipped with ventilators, increasing ICU admission and re-admissions in developed countries, and the favorable reimbursement scenario.

➡️ 𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐅𝐨𝐫 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=423097

Research Coverage:

The report analyzes the respiratory care devices market and aims at estimating the market size and future growth potential of this market based on various segments such as product, disease indication, end user and region. The report also includes a product portfolio matrix of various respiratory care devices available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall respiratory care devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This release was published on openPR.